{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:25:33Z","timestamp":1776086733211,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003610.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000}}],"reference-count":237,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003610.pub4","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T16:10:55Z","timestamp":1615479055000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antibiotics for secondary prevention of coronary heart disease"],"prefix":"10.1002","volume":"2021","author":[{"given":"Naqash J","family":"Sethi","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Safi","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Kwasi","family":"Korang","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asbj\u00f8rn","family":"Hr\u00f3bjartsson","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark; Department of Clinical Research, University of Southern Denmark; Odense Denmark"},{"name":"Open Patient data Explorative Network (OPEN); Odense University Hospital; Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Skoog","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"},{"name":"Clinical Study Support; Clinical Studies Sweden - Forum South; Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"},{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"},{"name":"Department of Regional Health Research, The Faculty of Health Sciences; University of Southern Denmark; Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus C","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"},{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"},{"name":"Department of Regional Health Research, The Faculty of Health Sciences; University of Southern Denmark; Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"10.1002\/14651858.CD003610.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.99.12.1540","article-title":"Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) Study","volume":"99","author":"Anderson","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.102.15.1755","article-title":"Randomized secondary prevention trial of azithromycin in patients with coronary artery disease. Primary clinical results of the ACADEMIC study","volume":"102","author":"Muhlestein","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa043526","article-title":"Azithromycin for the secondary prevention of coronary events","volume":"352","author":"Grayston","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003610.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S579","DOI":"10.1086\/315628","article-title":"Description and status of the azithromycin and coronary events study (ACES)","volume":"181","author":"Jackson","year":"2000","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0005|cit5","unstructured":"Azithromycin and Coronary Events Study (ACES) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00000617"},{"issue":"150","key":"10.1002\/14651858.CD003610.pub4-BIB0006|cit6","first-page":"11","article-title":"Oral spiramycin for prevention of restenosis in coronary arteries","volume":"9","author":"Aleksiadi","year":"2007","journal-title":"Georgian Medical News"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.CIR.0000054613.57105.06","article-title":"Antibiotic therapy after acute myocardial infarction","volume":"107","author":"Zahn","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(03)12706-7","article-title":"Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial","volume":"361","author":"Cercek","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0009|cit9","first-page":"525","article-title":"Effect of clarithromycin on inflammatory markers in patients with atherosclerosis","volume":"10","author":"Berg","year":"2003","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/427111","article-title":"Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events","volume":"40","author":"Berg","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1128\/JCM.43.3.1325-1329.2005","article-title":"Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial","volume":"43","author":"Berg","year":"2005","journal-title":"Journal of Clinical Microbiology"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1128\/AAC.48.11.4183-4188.2004","article-title":"Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Berg","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000128994","article-title":"Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease","volume":"111","author":"Gluud","year":"2008","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000022705","article-title":"Intervention with clarithromycin in patients with stable coronary heart disease. The CLARICOR trial design","volume":"1","author":"Hansen","year":"2001","journal-title":"Heart Drug"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diagmicrobio.2009.11.011","article-title":"Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial","volume":"66","author":"Hilden","year":"2010","journal-title":"Diagnostic Microbiology and Infectious diseases"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/FJC.0b013e3181c87e37","article-title":"Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease","volume":"55","author":"Jensen","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"7532","key":"10.1002\/14651858.CD003610.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.38666.653600.55","article-title":"Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with coronary heart disease: CLARICOR trial","volume":"332","author":"Jespersen","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/dkp190","article-title":"Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial","volume":"64","author":"Jespersen","year":"2009","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0019|cit19","unstructured":"The CLARICOR trial: effect of clarithromycin on mortality and morbidity in patients with ischemic heart disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00121550"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000324533","article-title":"Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?","volume":"118","author":"Winkel","year":"2011","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2015.01.020","article-title":"Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular mortality over 10 years in the CLARICOR randomised, blinded clinical trial","volume":"182","author":"Winkel","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/14017430902874305","article-title":"Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies","volume":"43","author":"Paakkanen","year":"2009","journal-title":"Scandinavian Cardiovascular Journal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.CIR.0000012544.07696.1F","article-title":"Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome","volume":"105","author":"Sinisalo","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejim.2003.07.001","article-title":"Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study","volume":"14","author":"Gabriel","year":"2003","journal-title":"European Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","article-title":"Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction","volume":"96","author":"Gupta","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2004.01.016","article-title":"Effecs of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: a double-blind, randomized, placebo-controlled study","volume":"148","author":"Hillis","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.amjcard.2004.08.018","article-title":"Effect of Azithromycin therapy on coronary circulation in patients with coronary artery disease","volume":"94","author":"Hyodo","year":"2004","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00392-008-0722-1","article-title":"Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting","volume":"98","author":"Ikeoka","year":"2009","journal-title":"Clinical Research in Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(00)05181-3","article-title":"Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial","volume":"357","author":"Neumann","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/44.3.411","article-title":"Safety and effect on anti-Chlamycia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease","volume":"44","author":"Jackson","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ahj.2005.01.024","article-title":"A randomized trial in patients undergoing percutaneous coronary angioplasty: roxithromycin does not reduce clinical restenosis but angioplasty increases antibody concentrations against Chlamydia pneumoniae","volume":"150","author":"Kaehler","year":"2005","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD003610.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4070\/kcj.2004.34.8.743","article-title":"A randomized trial for the secondary prevention by azithromycin in korean patients with acute coronary syndrome after percutaneous coronary intervention","volume":"34","author":"Kim","year":"2004","journal-title":"Korean Circulation Journal"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3349\/ymj.2012.53.1.68","article-title":"Effects of combination therapy with celecoxib and doxycycline on neointimal hyperplasia and inflammatory biomarkers in coronary artery disease patients treated with bare metal stents","volume":"53","author":"Kim","year":"2012","journal-title":"Yonsei Medical Journal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00011-013-0704-2","article-title":"The effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial","volume":"63","author":"Kormi","year":"2014","journal-title":"Inflammation Research"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0002-9149(02)03417-3","article-title":"Effect of short-term antibiotic treatment on Chlamydia Pneumoniae and peripheral endothelial function","volume":"91","author":"Kuvin","year":"2003","journal-title":"American Journal of Cardiology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003610.pub4-BIB0036|cit36","first-page":"S669","article-title":"Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial","volume":"84","author":"Leowattana","year":"2001","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.ATV.0000121571.78696.dc","article-title":"Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial","volume":"24","author":"Brown","year":"2004","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/hc1102.105649","article-title":"Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection","volume":"105","author":"Parchure","year":"2002","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD003610.pub4-BIB0039|cit39","first-page":"O30","article-title":"Results of interventional treatment of coronary heart disease (OCI) in patients treated with antibio","volume":"55","author":"Pieniazek","year":"2001","journal-title":"Kardiologia Polska"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMoa043528","article-title":"Antibiotic treatment of chlamydia pneumoniae after acute coronary syndrome","volume":"352","author":"Cannon","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD003610.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0002-9149(02)02201-4","article-title":"Design of the pravastatin or atorvastatin evaluation and infection therapy (PROVE IT)-TIMI 22 trial","volume":"89","author":"Cannon","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0043|cit43","first-page":"237","article-title":"Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events","volume":"41","author":"Radoi","year":"2003","journal-title":"Romanian Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(97)07201-2","article-title":"Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study","volume":"350","author":"Gurfinkel","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/euhj.1998.1283","article-title":"Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes","volume":"20","author":"Gurfinkel","year":"1999","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0046|cit46","first-page":"22","article-title":"Effects of doxycycline on left ventricular remodeling in patients with acute anterior myocardial infarction undergoing primary angioplasty: a randomized clinical trial","volume":"20","author":"Sanati","year":"2019","journal-title":"Iranian Heart Journal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0047|cit47","unstructured":"Protection of the heart with doxycycline during coronary artery bypass grafting https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00246740"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1097\/CCM.0b013e318292373c","article-title":"Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass","volume":"41","author":"Schulze","year":"2013","journal-title":"Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00005344-200010000-00018","article-title":"The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease","volume":"36","author":"Semaan","year":"2000","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/41.1.85","article-title":"The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors, and forearm basal nitric oxide production","volume":"41","author":"Sinisalo","year":"1998","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD003610.pub4-BIB0051|cit51","first-page":"106","article-title":"The effects of ciprofloxacin on inflammatory markers in patients with acute coronary syndrome","volume":"109","author":"Stojanovic","year":"2011","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/WNF.0000000000000238","article-title":"Perioperative use of erythromycin reduces cognitive decline after coronary artery bypass grafting surgery: a pilot study","volume":"40","author":"Thomaidou","year":"2017","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2017.03.125","article-title":"Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial","volume":"240","author":"Cerisano","year":"2017","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurheartj\/eht420","article-title":"Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial","volume":"35","author":"Cerisano","year":"2014","journal-title":"European Heart Journal"},{"issue":"13 (supplement)","key":"10.1002\/14651858.CD003610.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"E349","DOI":"10.1016\/S0735-1097(12)60350-7","article-title":"Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction and the ominous progression to adverse remodeling (TIPTOP). A randomized controlled trial","volume":"59","author":"Cerisano","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0056|cit56","unstructured":"Tetracycline (Doxycycline) and post myocardial infarction remodeling (TIPTOP) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00469261"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/01.CIR.99.12.1555","article-title":"Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease","volume":"99","author":"Torgano","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1600-051X.2007.01104.x","article-title":"Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease","volume":"34","author":"T\u00fcter","year":"2007","journal-title":"Journal of Clinical Periodontology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0059|cit59","first-page":"213","article-title":"The effects of clarithromycin treatment on cardiac events in acute coronary syndrome patients","volume":"4","author":"\u00dct\u00fck","year":"2004","journal-title":"Anatolian Journal of Cardiology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003610.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S572","DOI":"10.1086\/315634","article-title":"Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (Weekly Intervention With Zithromax (azithromycin) for Atherosclerosis and its Related Disorders) trial","volume":"181","author":"Dunne","year":"2000","journal-title":"Journal of Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jama.290.11.1459","article-title":"Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: a randomized controlled trial","volume":"290","author":"O'Conner","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-5223(19)38025-0","article-title":"Cardiothoracic surgery in the antipodes","volume":"78","author":"Barratt-Boyes","year":"1979","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0063|cit63","first-page":"71","article-title":"Comparative characteristics of the clinical efficacy of penicillins in treating angina","volume":"2","author":"Bondarenko","year":"1977","journal-title":"Voenno-Medicinskij Zurnal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000253854","article-title":"Preventing restenosis after implantation of bare stents with oral rapamycin: a randomized angiographic and intravascular ultrasound study with a 5-year clinical follow-up","volume":"115","author":"Cernigliaro","year":"2010","journal-title":"Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1083-4389.2004.00271.x","article-title":"Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes","volume":"9","author":"Elizalde","year":"2004","journal-title":"Helicobacter"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-5223(19)38034-1","article-title":"The value of prophylactic antibiotics in aorta-coronary bypass operations","volume":"78","author":"Fong","year":"1979","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0067|cit67","first-page":"58","article-title":"Effect of therapy with antibiotics on lipid metabolism and antioxidant reserve of patients with ischemic heart disease during Chlamydia Pneumoniae infection","volume":"12","author":"Klochkov","year":"2005","journal-title":"Kardiologiia"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1590-8658(01)80711-8","article-title":"Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty","volume":"33","author":"Kowalski","year":"2001","journal-title":"Digestive and Liver Disease"},{"issue":"8","key":"10.1002\/14651858.CD003610.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jacc.2005.12.052","article-title":"Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis","volume":"47","author":"Rodriquez","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.0000138935.17503.35","article-title":"Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis","volume":"110","author":"Hausleiter","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0071|cit71","first-page":"1142","article-title":"Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis","volume":"2","author":"Kufner","year":"2009","journal-title":"Journal of the American College of Cardiology: Cardiovascular Intervention"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0072|cit72","first-page":"967","article-title":"Treatment of recurrent angina in children with clindamycin. A multicenter study","volume":"106","author":"Pan","year":"1986","journal-title":"Revue m\u00e9dicale de la Suisse romande"},{"issue":"4 (special)","key":"10.1002\/14651858.CD003610.pub4-BIB0073|cit73","first-page":"1731","article-title":"Effect of doxycycline and atorvastatin on improving exercise tolerance in patients with angina pectoris","volume":"31","author":"Song","year":"2018","journal-title":"Pakistan Journal of Pharmaceutical Sciences"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Stone AF Mendall MA Camm AJ Northfield TC Antibiotics in the treatment of coronary heart disease Medical Research Society 2000","DOI":"10.1042\/cs100001Pb"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/01.CIR.0000027820.66786.CF","article-title":"Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes","volume":"106","author":"Stone","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ccd.22301","article-title":"Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation","volume":"75","author":"Stojkovic","year":"2010","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/49.2.411","article-title":"Modulation of oxidative burst of neutrophils by doxycycline in patients with acute myocardial infarction","volume":"49","author":"Takeshita","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0078|cit78","first-page":"411","article-title":"Randomized trial with clarithromycin in myocardial infarction.","volume":"48","author":"Vergassola","year":"2000","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0079|cit79","unstructured":"Changes in myocardial biomechanics and early short-term doxycycline therapy in patients with primary anterior STEMI (MASTARD) https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02562651"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0080|cit80","unstructured":"Anti-chlamydophila antibiotic combination therapy in the treatment of patients with Coronary Heart Disease https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=374503&isReview=true"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0081|cit81","unstructured":"newman H Borody T rajaratnam R Juergens C Tsaylor D Protocol for a phase IIa, prospective study to evaluate the safety and measure efficacy of anti-chlamydophila antibiotic combination (ACAC) therapy comprising 100mg doxycycline, 500mg azithromycin and 300mg rifabutin in the treatment of patients with coronary heart disease (CHD) https:\/\/clinicaltrials.gov\/ProvidedDocs\/08\/NCT03618108\/Prot_SAP_000.pdf"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0082|cit82","unstructured":"Doxycycline to protect heart muscle after heart attacks https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03508232"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0083|cit83","unstructured":"Effect of Doxycycline on cardiac remodelling in STEMI patients https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03960411"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0084|cit84","unstructured":"Doxycycline as a cardioprotective agent in ST-elevation myocardial infarction: a pilot study addressing pre- reperfusion administration https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12618000467235"},{"issue":"10","key":"10.1002\/14651858.CD003610.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0086|cit86","first-page":"318","article-title":"Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials","volume":"7","author":"Almalki","year":"2014","journal-title":"American Health & Drug Benefits"},{"issue":"7168","key":"10.1002\/14651858.CD003610.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3855\/jidc.7363","article-title":"Lack of strong association of Chlamydia pneumoniae and atherosclerosis in a Jordanian population","volume":"10","author":"Al-Younes","year":"2016","journal-title":"Journal of Infection in Developing Countries"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"08","DOI":"10.12703\/P7-08","article-title":"Pathophysiology of coronary artery disease leading to acute coronary syndromes","volume":"7","author":"Ambrose","year":"2015","journal-title":"F1000Prime Reports"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF01488805","article-title":"Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils","volume":"20","author":"Anderson","year":"1996","journal-title":"Inflammation"},{"issue":"12","key":"10.1002\/14651858.CD003610.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.99.12.1540","article-title":"Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study","volume":"99","author":"Anderson","year":"1999","journal-title":"Circulation"},{"issue":"21","key":"10.1002\/14651858.CD003610.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.293.21.2641","article-title":"Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials","volume":"293","author":"Andraws","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0528.2010.00582.x","article-title":"Association between periodontal pathogens and risk of nonfatal myocardial infarction","volume":"39","author":"Andriankaja","year":"2011","journal-title":"Community Dentistry and Oral Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5539\/gjhs.v8n4p260","article-title":"Association of Chlamydia pneumoniae infection with atherosclerotic plaque formation","volume":"8","author":"Assar","year":"2015","journal-title":"Global Journal of Health Science"},{"issue":"8","key":"10.1002\/14651858.CD003610.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2146\/ajhp060539","article-title":"Azithromycin for the secondary prevention of coronary artery disease: a meta-analysis","volume":"64","author":"Baker","year":"2007","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ja.2005.1","article-title":"Bioactive microbial metabolites","volume":"58","author":"Berdy","year":"2005","journal-title":"The Journal of Antibiotics"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728214.2017.1269743","article-title":"Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis","volume":"22","author":"Bertrand","year":"2016","journal-title":"Expert Opinion on Emerging Drugs"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1067\/mhj.2003.20","article-title":"Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results?","volume":"145","author":"Bloemenkamp","year":"2003","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/157488610789869184","article-title":"Antimicrobial agents-associated with QT interval prolongation","volume":"5","author":"Bril","year":"2010","journal-title":"Current Drug Safety"},{"issue":"7","key":"10.1002\/14651858.CD003610.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.ATV.0000167525.69400.9c","article-title":"Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs","volume":"25","author":"Brodala","year":"2005","journal-title":"Arteriosclerosis, Thrombolysis, and Vascular Biology"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/317938","article-title":"Atherosclerosis in apoE knockout mice infected with multiple pathogens","volume":"183","author":"Burnett","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"16","key":"10.1002\/14651858.CD003610.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMoa043528","article-title":"Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome","volume":"352","author":"Cannon","year":"2005","journal-title":"NEJM"},{"issue":"20","key":"10.1002\/14651858.CD003610.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","article-title":"The role of macrolide antibiotics in increasing cardiovascular risk","volume":"66","author":"Cheng","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD003610.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/AAC.33.9.1634","article-title":"In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)","volume":"33","author":"Chirgwin","year":"1989","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiology and Molecular Biology Reviews"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","article-title":"Immunomodulatory effects of quinolones","volume":"3","author":"Dalhoff","year":"2003","journal-title":"The Lancet Infectious Diseases"},{"issue":"9075","key":"10.1002\/14651858.CD003610.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(97)03079-1","article-title":"Chronic infections and coronary heart disease: is there a link?","volume":"350","author":"Danesh","year":"1997","journal-title":"Lancet"},{"issue":"7138","key":"10.1002\/14651858.CD003610.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/bmj.316.7138.1130","article-title":"Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies","volume":"316","author":"Danesh","year":"1998","journal-title":"BMJ"},{"issue":"7255","key":"10.1002\/14651858.CD003610.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"issue":"7255","key":"10.1002\/14651858.CD003610.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bmj.321.7255.208","article-title":"Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/euhj.2001.2801","article-title":"Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis","volume":"23","author":"Danesh","year":"2002","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2014.08.050","article-title":"Antibodies to periodontal pathogens are associated with coronary plaque remodeling but not with vulnerability or burden","volume":"237","author":"De Boer","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0114|cit114","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"25 Suppl 2","key":"10.1002\/14651858.CD003610.pub4-BIB0117|cit117","first-page":"S76","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Eckel","year":"2014","journal-title":"Circulation"},{"issue":"7109","key":"10.1002\/14651858.CD003610.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving\u00a0cross-over\u00a0trials: methodological issues","volume":"31","author":"\u00a0Altman","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0120|cit120","unstructured":"Guideline on multiplicity issues in clinical trials European Medicines Agency 2017"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1592\/phco.24.4.338.33181","article-title":"Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials","volume":"24","author":"Etminan","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0008-6363(02)00544-8","article-title":"Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice","volume":"56","author":"Ezzahiri","year":"2002","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/ejvs.2002.1913","article-title":"Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice","volume":"26","author":"Ezzahiri","year":"2003","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.rec.2013.10.002","article-title":"The epidemiology of coronary heart disease","volume":"67","author":"Ferreira-Gonzalez","year":"2014","journal-title":"Revista Espanola de Cardiologia (English Edition)"},{"issue":"24","key":"10.1002\/14651858.CD003610.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"60","author":"Fihn","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"378658","DOI":"10.1155\/2015\/378658","article-title":"Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis","volume":"2015","author":"Filardo","year":"2015","journal-title":"Mediators of Inflammation"},{"issue":"9","key":"10.1002\/14651858.CD003610.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.CIR.98.9.845","article-title":"Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators","volume":"98","author":"Folsom","year":"1998","journal-title":"Circulation"},{"issue":"Pt 12","key":"10.1002\/14651858.CD003610.pub4-BIB0128|cit128","first-page":"1568","article-title":"Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries","volume":"58","author":"Marcelino","year":"2009","journal-title":"Journal of Medical Microbiology"},{"issue":"9","key":"10.1002\/14651858.CD003610.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/1568026033452159","article-title":"Macrolide antibiotics: binding site, mechanism of action, resistance","volume":"3","author":"Gaynor","year":"2003","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000128994","article-title":"Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease","volume":"111","author":"Gluud","year":"2008","journal-title":"Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"e00438","DOI":"10.1128\/AAC.00438-18","article-title":"Systematic review, meta-analysis, and network meta-analysis of the cardiovascular safety of macrolides","volume":"62","author":"Gorelik","year":"2018","journal-title":"Antimicrobial Agents Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1902\/jop.2007.060301","article-title":"Periodontal destruction is associated with coronary artery disease and periodontal infection with acute coronary syndrome","volume":"78","author":"Gotsman","year":"2007","journal-title":"Journal of Periodontology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0134|cit134","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"16","key":"10.1002\/14651858.CD003610.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa043526","article-title":"Azithromycin for the secondary prevention of coronary events","volume":"352","author":"Grayston","year":"2005","journal-title":"NEJM"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/euhj.1998.1283","article-title":"Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study","volume":"20","author":"Gurfinkel","year":"1999","journal-title":"European Heart Journal"},{"issue":"7650","key":"10.1002\/14651858.CD003610.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0139|cit139","first-page":"CD011825","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication","volume":"1","author":"Hansen","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"20","key":"10.1002\/14651858.CD003610.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD003610.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0143|cit143","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0144|cit144","unstructured":"Higgins JPT Deeks JJ Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0145|cit145","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1503\/cmaj.112161","article-title":"Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis","volume":"185","author":"Hizo-Abes","year":"2013","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0147|cit147","volume-title":"1997 CFR & ICH Guidelines. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice","volume":"1","year":"1997"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.atherosclerosis.2004.10.034","article-title":"Antibiotics for vascular diseases: a meta-analysis of randomized controlled trials","volume":"179","author":"Illoh","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"i843","DOI":"10.1136\/bmj.i843","article-title":"Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study","volume":"352","author":"Inghammar","year":"2016","journal-title":"BMJ"},{"issue":"19","key":"10.1002\/14651858.CD003610.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0152|cit152","first-page":"Ed000111","article-title":"Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews","volume":"3","author":"Jakobsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/FJC.0b013e3181c87e37","article-title":"Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease","volume":"55","author":"Jensen","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"7532","key":"10.1002\/14651858.CD003610.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.38666.653600.55","article-title":"Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial","volume":"332","author":"Jespersen","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10096-016-2810-x","article-title":"Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China","volume":"36","author":"Jiang","year":"2017","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3904\/kjim.2007.22.3.152","article-title":"The association between current Helicobacter pylori infection and coronary artery disease","volume":"22","author":"Jin","year":"2007","journal-title":"Korean Journal of Internal Medicine"},{"issue":"9709","key":"10.1002\/14651858.CD003610.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0158|cit158","first-page":"341","article-title":"Chlamydia pneumoniae antibodies and markers of inflammation in patients with cardiovascular diseases","volume":"106","author":"\u00a0Cvachova","year":"2005","journal-title":"Bratislavsk\u00e9 Lek\u00e1rske Listy"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between small and large randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD003610.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.ATV.13.10.1501","article-title":"Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain","volume":"13","author":"Kuo","year":"1993","journal-title":"Arteriosclerosis and Thrombosis"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/cid\/cis664","article-title":"Fluoroquinolones and the risk of serious arrhythmia: a population-based study","volume":"55","author":"Lapi","year":"2012","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fcvm.2016.00030","article-title":"Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery Disease","volume":"3","author":"Lawson","year":"2016","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0163|cit163","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"48","key":"10.1002\/14651858.CD003610.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.3748\/wjg.v12.i48.7815","article-title":"H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease","volume":"12","author":"\u00a0Giordano","year":"2006","journal-title":"World Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD003610.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1253\/circj.CJ-09-0706","article-title":"Inflammation in atherosclerosis: transition from theory to practice","volume":"74","author":"Libby","year":"2010","journal-title":"Circulation Journal"},{"issue":"7347","key":"10.1002\/14651858.CD003610.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.87.4.1130","article-title":"Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease","volume":"87","author":"Linnanmaki","year":"1993","journal-title":"Circulation"},{"issue":"44","key":"10.1002\/14651858.CD003610.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"e8273","DOI":"10.1097\/MD.0000000000008273","article-title":"Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0170|cit170","first-page":"Mr000033","article-title":"Industry sponsorship and research outcome","volume":"2","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"e20240","DOI":"10.1371\/journal.pone.0020240","article-title":"Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile","volume":"6","author":"Maekawa","year":"2011","journal-title":"PLoS One"},{"issue":"13","key":"10.1002\/14651858.CD003610.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/01.CIR.0000031567.10814.D8","article-title":"Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease","volume":"106","author":"Mahdi","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12663-009-0028-5","article-title":"Prevalence of periodontal pathogens in coronary atherosclerotic plaque of patients undergoing coronary artery bypass graft surgery","volume":"8","author":"Mahendra","year":"2009","journal-title":"Journal of Maxillofacial and Oral Surgery"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0970-9290.159164","article-title":"Prevalence of eight putative periodontal pathogens in atherosclerotic plaque of coronary artery disease patients and comparing them with noncardiac subjects: a case-control study","volume":"26","author":"Mahendra","year":"2015","journal-title":"Indian Journal of Dental Research"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/aoms.2015.50772","article-title":"Putative consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation","volume":"12","author":"Matusiak","year":"2016","journal-title":"Archives of Medical Science"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/hrt.71.5.437","article-title":"Relation of Helicobacter pylori infection and coronary heart disease","volume":"71","author":"Mendall","year":"1994","journal-title":"British Heart Journal"},{"issue":"7038","key":"10.1002\/14651858.CD003610.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bmj.312.7038.1061","article-title":"C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study","volume":"312","author":"Mendall","year":"1996","journal-title":"BMJ"},{"issue":"9128","key":"10.1002\/14651858.CD003610.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD003610.pub4-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0181|cit181","doi-asserted-by":"crossref","unstructured":"Montalescot G Sechtem U Achenbach S Andreotti F Arden C Buday A 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology European Heart Journal 2013 34 38 2949 3003","DOI":"10.1093\/eurheartj\/eht296"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/aje\/kwx319","article-title":"Long-term risk of acute myocardial infarction, stroke, and death with outpatient use of clarithromycin: a retrospective cohort study","volume":"187","author":"Mosholder","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0183|cit183","first-page":"e38","article-title":"Heart Disease and Stroke Statistics-2016 Update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD003610.pub4-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0735-1097(96)00055-1","article-title":"Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease","volume":"27","author":"Muhlestein","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1753944709345598","article-title":"Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes","volume":"3","author":"Pesonen","year":"2009","journal-title":"Therapeutic Advances in Cardiovascular Diseases"},{"issue":"29","key":"10.1002\/14651858.CD003610.pub4-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10517-015-2941-6","article-title":"Chlamydia pneumoniae and immunoinflammatory reactions in an unstable atherosclerotic plaque in humans","volume":"159","author":"Pigarevskii","year":"2015","journal-title":"Bulletin of Experimental Biology and Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/520196","article-title":"Optimal use of modern antibiotics: emerging trends","volume":"29","author":"Polk","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.CIR.0000021125.83697.21","article-title":"Predisposition to atherosclerosis by infections: role of endothelial dysfunction","volume":"106","author":"Prasad","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD003610.pub4-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1902\/jop.2007.060062","article-title":"Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries","volume":"78","author":"Pucar","year":"2007","journal-title":"Journal of Periodontology"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.hjr.0000129745.38217.39","article-title":"High serum antibody levels to Porphyromonas gingivalis predict myocardial infarction","volume":"11","author":"Pussinen","year":"2004","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI119076","article-title":"Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability","volume":"98","author":"Rajagopalan","year":"1996","journal-title":"Journal of Clinical Investigation"},{"issue":"7","key":"10.1002\/14651858.CD003610.pub4-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1902\/jop.2006.050336","article-title":"Bacterial profile and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome","volume":"77","author":"Renvert","year":"2006","journal-title":"Journal of Periodontology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0194|cit194","unstructured":"The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"issue":"9","key":"10.1002\/14651858.CD003610.pub4-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.CIR.99.9.1161","article-title":"Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction","volume":"99","author":"Ridker","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.101.3.252","article-title":"Infections, inflammation, and the risk of coronary heart disease","volume":"101","author":"Roivainen","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.intimp.2005.10.012","article-title":"Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases","volume":"6","author":"Romano Carratelli","year":"2006","journal-title":"International Immunopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0198|cit198","first-page":"858","article-title":"Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis","volume":"106","author":"Rosenfeld","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"NEJM"},{"issue":"8618","key":"10.1002\/14651858.CD003610.pub4-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","article-title":"Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction","volume":"2","author":"Saikku","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.atherosclerosis.2014.01.023","article-title":"Association between Chlamydophila pneumoniae infection and risk of coronary heart disease for Japanese: the JPHC study","volume":"233","author":"Sakurai-Komada","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study","volume":"187","author":"Savovic","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD003610.pub4-BIB0206|cit206","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Schunemann","year":"2003","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0207|cit207","unstructured":"Schunemann HJ Brozek J Guyatt G Oxman AD GRADE handbook for grading quality of evidence and strength of recommendation. Available from http:\/\/gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html The Grade Working Group 2013"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0208|cit208","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Akl E Guyatt GH on behalf of the Cochrane Applicability and Recommendations Methods Group Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0209|cit209","first-page":"341","article-title":"Association of Helicobacter pylori with coronary artery disease and myocardial infarction assessed by myocardial perfusion imaging","volume":"16","author":"Shmuely","year":"2014","journal-title":"Israel Medicine Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0210|cit210","first-page":"158","article-title":"Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques","volume":"82","author":"Shor","year":"1992","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0211|cit211","unstructured":"Skoog M Saarim\u00e4ki J Gluud C Scheinin M Erlendsson K Aamdal S Transparency and registration in clinical research in the Nordic countries (Report). Nordic Trial Alliance. NordForsk Oslo. Norway Nordic Trial Alliance"},{"issue":"23","key":"10.1002\/14651858.CD003610.pub4-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association","volume":"58","author":"Benjamin","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"187103","DOI":"10.1155\/2011\/187103","article-title":"Sex differences in drug disposition","volume":"2011","author":"Soldin O","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archinte.166.5.554","article-title":"Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study","volume":"166","author":"Spahr","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0215|cit215","doi-asserted-by":"crossref","unstructured":"Steel HC Theron AJ Cockeran R Anderson R Charles F Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics Mediators of Inflammation 2012","DOI":"10.1155\/2012\/584262"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0216|cit216","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/hel.12234","article-title":"A meta-analysis of the association between Helicobacter pylori infection and risk of coronary heart disease from published prospective studies","volume":"21","author":"Sun","year":"2016","journal-title":"Helicobacter"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.ATV.11.3.547","article-title":"Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease","volume":"11","author":"Thom","year":"1991","journal-title":"Arteriosclerosis and Thrombosis"},{"issue":"3","key":"10.1002\/14651858.CD003610.pub4-BIB0219|cit219","first-page":"757","article-title":"Helicobacter pylori infection and coronary artery disease","volume":"31","author":"Vcev","year":"2007","journal-title":"Collegium Antropologicum"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2307\/3755196","article-title":"What is an antibiotic or an antibiotic substance?","volume":"39","author":"Waksman","year":"1947","journal-title":"Mycologia"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/archinte.164.19.2156","article-title":"Antibiotics for the secondary prevention of ischaemic heart disease: a meta-analysis of randomized controlled trials","volume":"164","author":"Wells","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.75.6.568","article-title":"Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men","volume":"75","author":"Whincup","year":"1996","journal-title":"Heart"},{"issue":"11","key":"10.1002\/14651858.CD003610.pub4-BIB0223|cit223","first-page":"1254","article-title":"Sex-based differences in drug activity","volume":"80","author":"Whitley","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0224|cit224","volume-title":"Global Atlas on Cardiovascular Disease Prevention and Control","author":"Mendis","year":"2011"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0225|cit225","unstructured":"World Health organization Cardiovascular diseases - Fact sheet N 317 WHO - Available from: www.who.int\/mediacentre\/factsheets\/fs317\/en\/"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000324533","article-title":"Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?","volume":"118","author":"Winkel","year":"2011","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2015.01.020","article-title":"Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the CLARICOR randomised, blinded clinical trial","volume":"182","author":"Winkel","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD003610.pub4-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2014.26","article-title":"Epidemiological studies of CHD and the evolution of preventive cardiology","volume":"11","author":"Wong","year":"2014","journal-title":"Nature Reviews Cardiology"},{"key":"10.1002\/14651858.CD003610.pub4-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40264-017-0533-2","article-title":"Managing cardiovascular risk of macrolides: systematic review and meta-analysis","volume":"40","author":"Wong","year":"2017","journal-title":"Drug Safety"},{"issue":"7644","key":"10.1002\/14651858.CD003610.pub4-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1902\/jop.2006.060081","article-title":"Evaluation of the incidence of periodontitis-associated bacteria in the atherosclerotic plaque of coronary blood vessels","volume":"78","author":"Zaremba","year":"2007","journal-title":"Journal of Periodontology"},{"issue":"6","key":"10.1002\/14651858.CD003610.pub4-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"e208199","DOI":"10.1001\/jamanetworkopen.2020.8199","article-title":"Association of azithromycin use with cardiovascular mortality","volume":"3","author":"Zaroff","year":"2020","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1002\/14651858.CD003610.pub4-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.CIR.103.1.45","article-title":"Prospective study of pathogen burden and risk of myocardial infarction or death","volume":"103","author":"Zhu","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9149(01)02192-0","article-title":"Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death","volume":"89","author":"Zhu","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0235|cit235","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003610","article-title":"Antibiotics for secondary prevention of coronary heart disease","author":"Monk-Hansen","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003610.pub4-BIB0236|cit236","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003610.pub3","article-title":"Antibiotics for secondary prevention of coronary heart disease","author":"Sethi","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003610.pub4-BIB0237|cit237","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003610.pub2","article-title":"Antibiotics for secondary prevention of coronary heart disease","author":"Skoog","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T21:23:27Z","timestamp":1724621007000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003610.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":237,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003610.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}